Susie Green & Mermaids UK - "Trans Kid Support Charity", Susie had her underage kid get GRS

suspect at some point Otterly will see the updates and she has actual knowledge of this sort of thing so will be able to provide chapter and verse of all the legal and ethical shortfalls involved with this latest scheme.
Legal not my speciality at all… I don’t know much about importing drugs illegally (oddly enough, like most of us I have never had to do this…)
But looks like the loophole is closing which is good.
Also good she’s lost her licence but really, what does it take to strike this woman off the register? She’s a disgraceful con artist and a danger to children and patients
 
Legal not my speciality at all… I don’t know much about importing drugs illegally (oddly enough, like most of us I have never had to do this…)
But looks like the loophole is closing which is good.
Also good she’s lost her licence but really, what does it take to strike this woman off the register? She’s a disgraceful con artist and a danger to children and patients
Cheers, thought there might be an overlap with your areas of expertise and the loopholes they were trying to exploit to provide drugs.
I think (ironically) that the problem is she is one of the sacred caste. A medical expert, specifically one focused on the current cultural war stuff. The more those people are shown to be wrong if not outright dangerously dishonest the less credibility they all have.
 
A bunch of "trans kids" have made an encampment outside the Department for Education and the ghoul in chief visited it.
GWGabDxXMAAz-ph.jpeg
Maya Forstater reports on it:
https://x.com/MForstater/status/1828912578631725277

The kids and fellow transhausen's mum Helen Islan ask for strange random adults to watch them sleep.
1724935726572.png
Top notch safeguarding as usual!
 
TERF Island is now forcing Mermaids to take the Case review into account:
Not to any meaningful degree. That's an utter whitewash of an investigation that has;

Said they were fine to send out chest binders to children and that those children could accept all the risks involved.
Claimed there was no inappropriate relationship between Mermaids and Tavistock.
Excused most of their stuff by letting them give advice via their forum since "those aren't Mermaids staff, they're volunteers tee hee."
Put more weight on some random EDI (DEI) group's finding than anything else.

Charity Commission should be lined up and shot.
 
An article got published on Susie's new grift. article / archive

Trans activists are flouting the ban on puberty blockers​


Jo Bartosch

5–7 minutes



Susie Green, former chief executive of disgraced trans-youth charity Mermaids, has returned to the field of so-called trans healthcare. Worryingly, she appears to have found a way to circumvent the UK’s ban on puberty-blocking drugs.

Her latest venture, Anne Trans Healthcare, known as ‘Anne’, is a service that promises to provide ‘personalised gender-affirming healthcare’ to both adults and children. After being dismissed from Mermaids in 2022, Green teamed up with fellow trans activist and HIV campaigner Lizzie Jordan to found Anne. Predictably, their approach is informed not by science, but by ideology. The service follows guidance from the dubious trans lobby group, the World Professional Association for Transgender Health (WPATH).
One of the services Anne offers is the prescription of puberty blockers to under-18s – something that was banned on the NHS and in private clinics earlier this year, following the Cass Review into youth gender services. Even before Dr Hilary Cass’s report was published, the evidence of their dangers was already clear to anyone whose vision wasn’t clouded by ideology. Research has identified serious and gut-churning potential side effects of puberty-blocking drugs, including lowering IQ, damaging fertility and weakening bone density. Today, most responsible clinicians are aware that giving distressed children experimental drugs is incredibly reckless.

Yet with almost admirable ingenuity, Anne has worked around the British ban, with ‘a legal route using a network of families’ outside the UK to provide puberty blockers abroad. Green justifies this by claiming that the ‘gender-affirming care’ her service offers ‘is a critical part of [children’s] healthcare journey’.
Anne’s treatments are open to any child who can afford them, so long as they can show they have support from a parent or guardian. For £150 per month, as well as a one-off £200 joining fee, they can purchase an ‘under-18s standard membership’. Medication costs are not included. Nor are the costs of travelling in person to an EU country where the drugs can be handed over or directly administered.

Green and Jordan are so emboldened by their faith in trans ideology that they feel confident dismissing the findings of the Cass Review. In an open letter to health secretary Wes Streeting, Green slams the NHS for implementing the report’s recommendations and repeats the grotesque lie that children experiencing gender dysphoria are more likely to kill themselves if not given puberty blockers.
Green says on her website that the NHS ban means families have been forced to ‘watch their children suffer as the medication that treated their gender dysphoria wears off’. She concludes, with unforgivable melodrama, that ‘for them, with puberty-blocking medication now forcefully withdrawn, the torture resumes and concerns about self-harm and suicide ideation become a reality’.

This attitude is particularly disturbing for Keith Jordan, founder of Our Duty, a support group for families of children who identify as transgender. He has urged policymakers to close the regulatory loopholes exploited by Anne. ‘Puberty blockers (and cross-sex hormones) are demonstrably harmful when used for transgender ideation’, he tells me. ‘Their purveyors must be fully aware of this. There is no clinical justification.’
He also points out that ‘this is not the first time Susie Green has sought to bypass the UK’s regulated health system’. Indeed, Green took her child, Jackie, to Thailand for his 16th birthday, where he underwent cross-sex surgery – a procedure that has always been illegal for under-18s in Britain, and has also since been banned for minors by the Thai government.

When discussing Jackie’s surgery afterwards, during a TED Talk no less, Green joked that the penile-inversion procedure had been difficult because ‘there wasn’t much there to work with’ – a grim reference to the fact that Jackie’s genitals had never properly developed due to puberty-blocking medication.
To support the sterilisation of one’s own child might be seen as irresponsible, or as a devastating mistake. But to make a career out of doing the same to other vulnerable children is surely unforgivable.
The AIDS infected troon she cofounded Anne with looks like he's skinwalking Mayim Byalik.
liz.png
 
Not sure what the baby troons get for £200 up front plus £150 a month. It brings to mind Michael Caine talking about his role in some shitty film: "I have never seen the film, but by all accounts it was terrible. However I have seen the house that it built, and it is terrific."
Archive here.
A complete support package for your gender-affirming healthcare journey.

✓ Intake sessions with the gender care therapeutic team to build your gender report

✓ Access to experienced, qualified doctors for treatment advice

✓ Access to qualified doctors for prescriptions if appropriate

✓ Initial intake blood test via our partner lab

✓ Any ongoing required blood tests

✓ Blood tests reviewed throughout the year by clinical experts

✓ Gender care reviews at three and six months with the therapeutic team

✓ Support and helpline

Interestingly they've deleted this page since the article came out, but it is still linked to internally on their website.

But anyway they'll handle all the standard stuff Gender GP was doing like blood tests. Then they'll arrange an EU doctor (say, a German doctor) to prescribe puberty blockers on what's called a cross-border prescription, that is valid in any EU member state (which is sort of what they were doing anyway).

Then they liase with someone in Berlin and get the kid to send an authorisation letter (probably through their service). This German person will file the prescription on the kid's behalf. Then the kid will fly to Germany and get the puberty blocker injection. Since no UK doctor prescribed it and no UK chemist dispensed it and the medication is not entering the UK, this is fully legal.

It's not too far off what they were attempting to do in Northern Ireland.
 
Just in case people were unsure if the NHS was trying to dodge the Cass guidance.


The NHS has been accused of ignoring the Cass review recommendations on transgender care for children.
Dr Hilary Cass’s report advised that under-18s should not be rushed into treatment which they may later regret following concerns about care at the Tavistock clinic.
However, a new NHS centre has snubbed the Cass review in favour of discredited transgender guidance that promotes both puberty blockers and surgery without age limits.
The Nottingham Young People’s Gender Service was founded in April to give psychological and social support to children with gender dysphoria who were former Tavistock patients and are currently taking or waiting to start puberty blockers.
In a job advertisement for a clinical psychologist position, the centre says it is “essential” to “practice [sic] in a gender affirming manner in line with” guidance from the controversial World Professional Association of Transgender Healthcare (WPATH).
The WPATH guidelines call for removing any minimum age to transition and lowering the age threshold for puberty blockers and surgery.
Campaigners fear the service is at risk of becoming “Tavistock version 2”.

Helen Joyce, the director of advocacy at human rights charity Sex Matters, said: “Dr Cass warned that [WPATH guidance] promoted childhood social transition without evidence that this was safe or beneficial.
“Earlier this year, leaked materials from WPATH revealed the cavalier attitude of many gender clinicians towards patient wellbeing and informed consent.
“The point of closing the disgraced Tavistock clinic in London was to learn from its mistakes and replace it with something better. This job ad is a deeply concerning sign that the Nottingham clinic risks becoming Tavistock v2.”
The NHS said the advert had used “old terminology” and was being amended when contacted by The Telegraph.
Dr Louise Irvine, the co-chairman of the Clinical Advisory Network on Sex and Gender, said: “It is extremely concerning that the Nottingham Young People Gender Service job advertisement indicates that it is continuing to follow the discredited medicalised ‘affirmative’ approach to children and young people with gender dysphoria.
“This flies in the face of the Cass review whose findings were supposedly accepted by NHS England and the government.
“The Cass review appraised WPATH’s latest guidelines and found they were based on very weak evidence. Court documents in the USA reveal that WPATH actively suppressed research it had commissioned that did not have the outcomes it wanted,” she added.

The job posting, which pays upward of £53,700, went live earlier this week and was raised in the House of Commons by Nick Timothy, a Tory MP. He asked for the Government to confirm that the Cass review would be implemented across the NHS.
Afterwards, he took to X, formerly Twitter, to state that “unfortunately, the Leader of the House [Lucy Powell MP] had failed to back Cass” in her response.
The new clinic – run by the Nottinghamshire Healthcare NHS Foundation Trust – said it will care for children taking puberty blockers aged 11 to 17.
It is understood that the service will be decommissioned once it has finished treating all former Tavistock patients.
Senior doctors at the centre are or have been members of WPATH, and have been openly critical of Dr Cass’s review, which found a lack of evidence to support prescribing puberty blockers to children and urged caution in the treatment of all under-25s.
Dr Walter Pierre Bouman, a senior doctor at the Nottingham Centre for Transgender Health and past president at WPATH, described the review as “poorly reasoned”. He added that there was “a fine line between naivety, narcissism and psychopathy”.
Prof Jon Arcelus is another doctor at the centre and was formerly a co-chairman of the committee responsible for developing the controversial WPATH guidance.
The advert for a psychologist to work with gender-questioning children made no mention of the Cass report, despite requiring knowledge of the WPATH guidance.
The guidelines include a chapter dedicated to eunuchs, which claims that males who identify as eunuchs can have their genitals removed.

The Cass review was highly critical of the WPATH guidance and its widespread use.
The final report said: “WPATH has been highly influential in directing international practice, although its guidelines were found by the University of York appraisal process to lack developmental rigour.”
It added that “instead of stating that some of its recommendations are based on clinical consensus, WPATH 8 overstates the strength of the evidence in making these recommendations”.
A spokesman from Bayswater Support Group, which advocates for evidence-based care on behalf of 600 families with trans-identifying children, said: “It is alarming to hear that despite Cass and NHS England distancing themselves from WPATH due its lack of credibility, its treatment guidelines are still being referenced as ‘essential’ knowledge for working with children at one of the new centres”.
An NHS spokesman said the service “provides additional mental health support to young people already referred to endocrine services following the closure of the GIDS clinic at Tavistock – and the trust has acknowledged that old terminology was used in the job advertisement and is amending it.
“All the NHS’s new children’s gender services are being established closely in line with recommendations from the Cass Review.”
Ifti Majid, the chief executive of Nottinghamshire Healthcare, said: “The Nottingham Young People’s Gender Service has been developed in line with NHS England’s national specification.
“This psychologist position is for a specialist to work with young people, who have already been referred on to a medical pathway by the GIDS prior to the closure of that service, to deliver psychological assessment and therapies in compliance with the recommendations set out in the Cass Review.”

And for added proof, the most telling bit underlined
The NHS trust that led a controversial gender clinic that prescribed puberty blockers to children is set to be merged in an effort to remain financially sustainable.
The Tavistock and Portman Trust, in London, has announced it is in the process of identifying a merger partner after years of substantial losses. The trust made the announcement months after the closure of its Gender Identity Development Service (Gids), the largest clinic treating children and adolescents experiencing gender dysphoria. The clinic closed in March after several controversies.
Michael Holland, the chief executive, said at the trust’s annual meeting on Tuesday: “We are very, very at risk because of our financial situation at this moment in time. One thing the board did was to think about and consider what a sustainable future for the organisation was going to look like… that led us to consider and search for a merger partner who would bring that to us.”



In the latest financial year the trust recorded a deficit of a little under £2.5 million with an underlying deficit of £6.2 million, according to Peter O’Neill, the interim chief financial officer.
O’Neill said: “We are now in a position where we have a cash deficit and we need cash support from the system to pay for bills for the staff, etc. All that feeds into a narrative that in its current form the trust will not be financially sustainable.”
The trust is working with Central and North West London Foundation Trust, in partnership with University College London and the London borough of Camden on a merger proposal. An official announcement is expected in the coming months.
However, governors and members have raised concerns that a merger could harm the institution’s legacy and remove its autonomy over service provision in the area.

Professor Michael Rustin, an elected governor of the trust, also questioned whether it was a result of the “difficulties” and “negative publicity” encountered by Gids. He told the meeting: “The idea that the trust is no longer sustainable, that it is too small, that it has a financial deficit, is that really credible for an institution of this reputation and previous long-term capability?
“There has been a picture in the trust that the actual real reason, the real motive of the merger of the trust, is that the NHS got absolutely fed up with us because of Gids because we attracted torrents of horrible publicity because of the way Gids worked. I think that some of it was the trust mismanagement but some of it was the fact that we got caught up in a huge culture war.”
Holland and John Lawlor, the chair of the trust, denied that Gids played any significant part in the discussion leading to the merger plans.


Holland said: “[NHS England] have been very supportive of the organisation. They talk about protecting the organisation, that’s how they’ve approached it, not about any punishment. It’s about protecting the legacy of the organisation, the importance of what it’s done and actually how we bring that to a wider [public].”
Lawlor added that Gids “never once” came up in any of the discussions he had been involved in as having had a “significant impact” on the merger plans.
A spokesman for the trust said that although the loss of Gids was a contributing factor to its financial situation, the trust had been reporting deficits before its closure. He added: “Before the decision to close Gids, and to set us on a more sustainable footing for the future, we’ve been exploring a merger which would help us to retain and grow our pioneering clinical, educational and research offerings.
“In late 2023 and throughout 2024, we held engagement sessions with our staff, patients, service users and students, to ensure a partnership will benefit those who use and interact with our services. We have been clear that any merger should allow us to continue to be a leader in mental health care and education and make a meaningful difference to people’s lives.”
Tavistock, which was founded in 1920 as a specialist mental health hospital, joined with the Portman in 2006 to become an NHS foundation mental health trust.

It was the largest provider of transgender services specialising in working with children until concerns were raised about overdiagnosis and medicalisation of young people. This year puberty blockers were made illegal and the centre was closed and replaced with six specialist clinics.
Two services, led by Great Ormond Street Hospital in London and Alder Hey Children’s Hospital in Liverpool, opened in April after the Gids closure. NHS England previously said the two services would be the first of up to eight specialist centres as part of the north and south hubs over the next two years.
Mermaids is part of the same rot and it's going nowhere anytime soon.
 
People who go abroad to sexually abuse kids can be prosecuted for it upon their return to the UK.

I don't see why this should be treated any differently.
It's a legal loophole. There are some medications that are illegal in some EU member States but legal in the UK, and vice versa. We've carried over a lot of the EU legislation.

Flunitrazepam (Rohypnol) is still sometimes prescribed in Germany for insomnia. No UK chemist can dispense it and no UK doctor can prescribe it. But a British citizen in Germany could get it prescribed by a German doctor and take it. It'd be seized at customs if they brougt it back to the UK, because it's scheduled. You can get a personal import license but I think that's only for foreign temporary visitors (tourists, short term working etc).

They're using this loophole plus the benefits of technology to get around the block, plus the fact the medication can be injected and there's no requirement to bring the actual meds home. To close this loophole you'd need to introduce primary legislation and while that's not entirely off the cards, I'm not sure it's going to be top priority for the Government right now.
Just in case people were unsure if the NHS was trying to dodge the Cass guidance.
The good news is this is in line with Cass. They are unable to prescribe puberty blockers to any new patients. However the way they were banned means patients currently on puberty blockers cannot have their prescription withdrawn. This is the last cohort on puberty blockers and no more children will be added based on current legislation, outside of a clinical trial.
 
The good news is this is in line with Cass. They are unable to prescribe puberty blockers to any new patients. However the way they were banned means patients currently on puberty blockers cannot have their prescription withdrawn. This is the last cohort on puberty blockers and no more children will be added based on current legislation, outside of a clinical trial.
Except they are taking on new staff specifically calling for them to be using WPATH as their guidelines.
In a job advertisement for a clinical psychologist position, the centre says it is “essential” to “practice [sic] in a gender affirming manner in line with” guidance from the controversial World Professional Association of Transgender Healthcare (WPATH).
While you are correct that it's not meant to be taking on new patients it's advertising for activist sorts and means they'll be bringing into the NHS yet more staff that will rebel against Cass and agitate for WPATH to be the sacred doctrine.
 
Mermaids seems to be on its last legs. Or, er fishtail.

r/LGBT's fundraiser for Mermaids

1730664000688.png
Mermaids is a UK charity working to support transgender, non-binary and gender diverse children, young people and their families. Mermaids' vision is a safe, inclusive society where trans children and young people are empowered to live their best lives.
Every donation made through Just Giving will allow Mermaids to support more young trans people, giving them the freedom to explore their gender identity and thrive.
The r/lgbt moderator team has chosen to support Mermaids, unfortunately Reddit is no longer matching donations.


The spiel on Reddit is a bit longer:

Mermaids is a charity in the uk supporting trans, non-binary and gender-diverse children, young people and their families. It is a charity that means a lot to many amongst our mod team, this sub and the wider LGBT community.

The charity is under attack from both right wing media, transphobic hate groups and the governments via the Charities Commission which began an investigation of Mermaids in 2022. This investigation recently concluded that the Mermaids had been mismanaged due to an inability to keep pace with demand, and did not issue advice that complied with the Cass Report, which was not released until 2024. This "mismanagement" was not misconduct which carries legal penalties and was not any misuse of funds, and the report states "Mermaids cooperated with [the] investigation and has been actively addressing the various concerns raised." The remedy implemented by the report was to "issue guidance" including about Mermaids talks about binders and puberty blockers. There was no regulatory action taken to restrict the operation of the charity and the finances are in order.

This report has affected the charity's ability to secure funding. We had applied for reddit community funds where reddit would match any funding raised, but reddit refused to support Mermaids. We do expect to have a second fundraiser supported by reddit launching shortly but Mermaids still needs your help.

Remember that those twats tried to destroy the LGB Alliance by having its charity status removed. Well well well...
 
Mermaids seems to be on its last legs. Or, er fishtail.
While I would love to dance on its corpse they do this shit all the time.
Much like the suicide threats Mermaids loves to toss out "we may have to close!" Heck, this is a Reddit one, I half expect it'll just be side grift.
 
People who go abroad to sexually abuse kids can be prosecuted for it upon their return to the UK.

I don't see why this should be treated any differently
Flunitrazepam (Rohypnol) is still sometimes prescribed in Germany for insomnia. No UK chemist can dispense it and no UK doctor can prescribe it. But a British citizen in Germany could get it prescribed by a German doctor and take it. It'd be seized at customs if they brougt it back to the UK, because it's scheduled. You can get a personal import license but I think that's only for foreign temporary visitors (tourists, short term working etc).
This is what I don't understand. If I set up a company in the UK that helps UK residents go to Germany to get these drugs - or, possibly a better example, if I set up a company in the UK that sells South-east Asian travel packages explicitly to paedophiles (and market these products as 'get around the UK laws that make sex with children illegal'), surely that entity can be (at least) struck off the companies register? There has to be some limit to what a company can do and still be a legal entity in the UK, surely? Surely it is possible to argue that "Anne"'s PB-provisioning is bringing the UK's regulatory system into disrepute?

Anyway, a group of gcs and an anonymous "Parent X" have been successful in their application for judicial review of the accreditation of GenderPlus (the chicken-shop place). This is from their crowd funder (updated archive):

High court Judge grants permission for Judicial Review.​

On Friday my solicitors heard from the High Court that Mr Justice Foxton had given me and parent X permission to challenge the decision of the CQC to license GenderPlus Hormone Clinic. The judge was very concerned that the CQC may have licensed GenderPlus without having all the necessary information it needed to assure itself that providing cross sex hormone treatment to teenagers was a safe treatment. The judge was also concerned that by granting licensing to GenderPlus the CQC was acting irrationally.

We now know that, in the light of the Cass Review, there are hugely significant concerns about cross sex hormone treatment. The consequences are lifelong and the evidence to support this treatment is currently extremely poor.

Our case will now proceed to trial. We are so grateful for those who have supported us thus far. We need to raise funds to get this case across the line and finally protect vulnerable teenagers from experimental treatment that is not evidenced and may have profound lifelong irreversible consequences. The serious and troubling question regarding the ability of young patients to give 'informed consent' to this treatment remains.

Please donate and share with others. Thank you so much.

Sue and Parent X
 
Things continue to get worse for Wobberley:
Singapore blocks access to online gender clinic GenderGP due to 'public health risk' (archive)
SINGAPORE: Authorities have blocked the website of online gender clinic GenderGP from users in Singapore as its doctors are not registered to practice here.

The teleconsultation platform offers services such as hormone therapy as well as prescriptions for puberty blockers.

Founded by English physician Helen Webberley in 2015, GenderGP is a registered entity in Singapore.

Responding to CNA's queries sent in June, the authorities said on Wednesday (Dec 4) that GenderGP is not a licensed healthcare provider under the Healthcare Services Act 2020.
"CNA" refers to the news outlet, "Channel News Asia." Funnily enough, I don't think they need to be licensed as a healthcare provider as they are registered as a software developer/publisher of videogames (I assume an attempt by Webberley to evade the scrutiny and extra regulation that tends to come with the medical/pharmaceutical services sector in any developed country).
"There is no assurance that GenderGP’s services are safe or effective. GenderGP’s prescriptions by doctors based outside Singapore are also not recognised in Singapore," said the Ministry of Health (MOH) and the Infocomm Media Development Authority (IMDA).

MOH had warned GenderGP on Oct 22 to stop providing medical services to Singapore-based users, after finding that the platform's doctors based outside the country had provided teleconsultation and issued a prescription to one person here.

"GenderGP has been warned not to re-offend," the authorities said, adding that failure to comply can lead to a fine of up to S$100,000 (US$74,000), a maximum jail term of 24 months or both. Repeat offenders face harsher penalties.
It seems like all they've done so far is block the website (like was done in the UK with several online chemists/pill mills selling hormones earlier in the year), but hopefully this is the beginning of the end of the Singapore chapter of Helen's grift.
 
The ban on the use of puberty blockers as a treatment for gender dysphoria has been made permanent. Mermaids was one of over 60 LGBT groups consulted (which does also include Sex Matters and the LGB Alliance, but also lots of trans rights groups). This consultation was required under the Medicines Act 1968 to make the ban permanent. It's unclear if there was a response from Mermaids as only 21 groups responded but the findings are here. There's also an Equality Impact Assessment which considers if this could be discriminatory (shockingly the answer is "no" because children getting treated for precocious puberty are - gasp - being treated for something else, so it's not discrimination against the protected characteristic of trans people).

Here's a brief overview of risks flagged by opponents to the ban:
pblck.png
It's worth noting that supporters of the ban did also flag potential mental health impacts. Sadly as this is a summary, we don't know the specifics, but it's interesting that the report notes the evidence base was a mix of "anecdotal evidence, peer reviewed journals and non-peer reviewed articles". Don't know what journal articles they're referencing but it's telling that they were probably swamped with "50,000 trans children tried to kill themselves yesterday because of this it's totally true, trust us". The other main risks flagged were attempting to get hold of illegal alternatives and lying to doctors about it impeding healthcare, plus kids who got prescriptions from EEA prescribers (i.e. the GenderGP route) struggling because no UK chemist could honour those prescriptions.

This consultation went to the Commission on Human Medicines, who invited the groups to make further representations (few did) but also spoke extensively to consultant paediatric endocrinologists, Baroness Cass, Professor Emily Simonoff and Professor Jane Hewitt. Professor Simonoff is a Professor of Child and Adolescent Psychiatry in the Child and Adolescent Mental Health Services (CAMHS) Neuropsychiatry Service, head of the Child and Adolescent Psychiatry department at the Institute of Psychiatry and lead for the CAMHS Clinical Academic Group at King's College London, along with being chair of the Mental Health Research Network for treatment of children with mental health problems and a member of the NICE guideline development group for treatment and diagnosis of autism in children and adolescents. I'm a bit unclear of what exactly Professor Hewitt's role is (she appears to have lead in using DNA sequencing to make genetic diagnoses of muscular dystrophy) but it seems she and Baroness Cass were acting as consultants into academic research around puberty blockers and decoding what clinical evidence exists. Basically the role of the CHM is to balance the consultation with weighted evidence from experts and prepare recommendations for consideration by the Health Secretary and Northern Irish Health Secretary

The recommendations were:

Recommendation 1​

The current prescribing and care pathway for GnRH agonists for gender incongruence and/or gender dysphoria presents an unacceptable safety risk for children and young people under 18 years without significant additional safeguards, including those detailed in the 2 recommendations below. The current restrictions that are set out in the temporary prohibition order should continue indefinitely for prescribers registered outside the UK.

Recommendation 2​

For UK private prescribers, the current restrictions that are in the temporary prohibition order should continue and there should be a review of the order in April 2027 and if required, at a later appropriate date, but no later than the end of the puberty suppressing hormone trial. When reviewing the order, the Secretary of State for Health and Social Care and the Minister of Health for Northern Ireland should assess whether and how the evidence and safety environment have evolved, including whether the additional safeguards set out in recommendation 3 have been put in place. The purpose of the assessment should be to consider whether at that point, GnRH agonists could be considered to have a safety profile that would enable them to be prescribed off label by competent clinicians working to common minimum care standards within an appropriate governance and multidisciplinary framework in the UK.

Recommendation 3​

The additional safeguards which should be put in place to facilitate safe UK prescribing of GnRH agonists for gender incongruence and/or gender dysphoria outside the puberty suppressing hormone trial include:

a) prescribers should complete a risk acknowledgment form with the patient and/or parents or carers when prescribing GnRH agonists for puberty suppression in children and young people under 18 years of age. This form should be identical across the UK’s 4 nations. CHM recommends that the Secretary of State for Health and Social Care and the Minister of Health for Northern Ireland should ask prescribers to do this and should write to their counterparts in Wales and Scotland asking them to do the same

b) it is important that a set of consistently audited common care standards for specialist gender services is developed for children and young people under 18 years of age, adopted and implemented for use in all parts of the UK by April 2027, in both public and private sectors, and adherence regularly assessed by the healthcare regulators. CHM recommends that the Secretary of State for Health and Social Care and the Minister of Health for Northern Ireland collaborate with their counterparts in Wales and Scotland on how to do this

c) there is an absence of long term safety and efficacy data for this population. DHSC should facilitate the development of a funded strategy for capturing and reporting long term safety and efficacy data across all UK gender specialist services. All children and young people who were prescribed GnRH agonists at the time of the temporary ban coming into place should be given the opportunity to participate in and co-design the studies


CHM recommendations in respect of wider implementation considerations​

Recommendation 4​

Mental health and wellbeing support for all children and young people with gender incongruence and/or gender dysphoria should be expedited and enhanced, irrespective of whether the prohibition order is made permanent or not.

Recommendation 5​

We have noted the reports that an unknown number of children and young people have been unable to find an NHS prescriber willing to manage prescribing of their GnRH agonists, where the prescribing had previously been by an EEA prescriber. Through the planned communication strategy (see recommendation 8), such young people should be invited to present to the NHS, through whichever route, and the NHS should ensure that they receive appropriate rapid specialist assessment of their needs, and access to other support as required. Where a decision is made to continue regularly prescribed GnRH agonists in these legacy individuals, this should be undertaken by specialist gender services.

Recommendation 6​

Those children and young people identified within recommendation 5 represent a vulnerable at-risk population. There should be an accelerated mental health service triage made available for all those children and young people aged under 18 who have experienced withdrawal of GnRH agonist treatment for puberty suppression as a direct result of the prohibition order.

Recommendation 7​

The planned puberty suppressing hormone trial will recruit children and young people under 18 years who have not had previous exposure to GnRH agonists. A clear exit strategy needs to be put into place for continuation of GnRH agonists when exiting the trial if this is the pathway agreed with the patient and/or parents or carers. This should be accompanied by data collection on the efficacy and safety of the GnRH agonists.

Recommendation 8​

An ongoing co-produced patient and/or parents or carers, and GP communication strategy should be prepared by DHSC working in collaboration with the four UK health services. This should include a plan detailing the timetable for enacting all the accepted CHM recommendations. The importance of further research in this area to understand the long-term efficacy and safety of the GnRH agonists should also be included in the communications plan.
So one of the big ones is that, as was already established, there's going to be a clinical trial of puberty blockers and that is the only way to get them prescribed for gender dysphoria in the UK. Following on from that, there will be a review of this ban in April 2027 (or otherwise when the trial concludes) to look at if there is indeed evidence of benefit (the report notes opponents were arguing there's an "absence of evidence of risk, which could demonstrate that puberty blockers might be safe").

It also specifically notes that whether or not the ban was implemented, there needs to be way more mental health support - and specifically for all the kids who were getting EU prescriptions from GenderGP and now can't, and mostly that there needs to be consistent care pathways. I've written about this before - basically, gender clinics tended to emerge independently of each other in different NHS trusts throughout the latter half of the 20th century. They often did not use evidenced based decision making but were driven by activist doctors and trans rights groups, especially after the 1990s. Because there's been so much complaining about gender clinics not doing enough and having excessive waiting times, trans rights groups brought a spotlight onto it right around when we were switching from Primary Care Trusts to NHS England as a commissioning body in 2013. A decade later, there's now basically one NHS looking at the whole picture and emphasising the need for evidence.

So in short, this permanent ban isn't guaranteed to stay on the books, and children are going to still be prescribed puberty blockers. But they'll only be allowed puberty blockers as guinea pigs and will be used to create a long term picture of the health impacts and wellbeing outcomes of puberty blockers in children. If there's evidence that puberty blockers provide more benefit than harm, then the ban will be lifted - but if that evidence isn't there, then they're banned for good. It's the most above board and fair approach that the UK and the NHS could possibly offer but I guarantee that there'll be so much screeching about this being "ideological" when, in many ways, it's actually the long term result of a lot of transgender activism around the NHS (and why some trans people thought the Cass Review could be a good thing, at least initially).
 

Archivos adjuntos

  • pblck.png
    pblck.png
    88.4 KB · Vistas: 59
Atrás
Top Abajo